Presentation of Biovitrum's Interim Report January - March, 2010
(Thomson Reuters ONE) -
The first quarter 2010 report will be published around 8.30 a.m. (CET) April 27.
The Biovitrum AB (publ)´s Interim Report for the first quarter 2010 will be
presented by Swedish Orphan Biovitrum´s CEO Martin Nicklasson and CFO Göran
Arvidson at a media and analyst meeting. The presentation will be held in
English and webcasted.
Time: Tuesday, April 27, 2010 at 2 p.m. (CET)
Venue: IVA, Grev Turegatan 16 Stockholm
Coffee will be served
Registration:
Please register for participation to Mikael Nilimaa
onmikael.nilimaa(at)zoomvision.se
telephone +46 702 699 322.
Webcast:
The presentation will be webcasted, Tuesday April 27 at 2 p.m.
(CET):www.biovitrum.com
Telephone dial in: UK: +44 (0) 207 509 5139, Swe+46 (0)8 505 202 70, US: +1
718 354 1226
___________________________________________________________________
The presentation material will be published on our web site after the meeting as
will the archived web cast, please go to: www.biovitrum.com
Welcome!
Erik Kinnman, EVP Investor Relations
Phone: +46 8 697 21 50,erik.kinnman(at)biovitrum.com
About Swedish Orphan Biovitrum
On January 14, 2010, Biovitrum AB (publ) completed the acquisition of Swedish
Orphan International Holding AB and created Swedish Orphan Biovitrum - a leading
company focused on treatment of rare diseases.
Swedish Orphan Biovitrum is a Swedish based specialty pharmaceutical company
with an international market presence. The company is focused on providing and
developing orphan and niche specialist pharmaceuticals to patients with high
medical needs. The portfolio consists of about 60 marketed products and an
emerging late stage clinical development pipe-line within rare diseases. Swedish
Orphan Biovitrum has pro-forma revenues 2009e of about 2 BSEK and approximately
500 employees. The head office is located in Sweden and the share (STO: BVT) is
listed on NASDAQ OMX Stockholm. For more information please visit
www.biovitrum.com
[HUG#1406559]
Invitation in PDF format: http://hugin.info/134557/R/1406559/360016.pdf
Unternehmensinformation / Kurzprofil:
Datum: 21.04.2010 - 17:32 Uhr
Sprache: Deutsch
News-ID 19445
Anzahl Zeichen: 0
contact information:
Town:
Stockholm
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 187 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Presentation of Biovitrum's Interim Report January - March, 2010"
steht unter der journalistisch-redaktionellen Verantwortung von
Biovitrum (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
